Condition
Nonsmall Cell Lung Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Nonsmall Cell Lung Cancer clinical trials that are recruiting, at sites in 2 countries (most in United States (4), China (4)). By phase: Phase 1 (3), Phase 2 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 2Countries
Newest Nonsmall Cell Lung Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| VMD-102 in liver cancer and other solid tumors | Phase 1/2 | Scottsdale, Arizona and 1 other locations | Recruiting | Jun 9, 2026 |
| AI helps a multidisciplinary team decide NSCLC treatment | — | Guangzhou, Guangdong | Recruiting | Jun 4, 2026 |
| Evaluating DZD6008 for advanced lung cancer with EGFR mutations | Phase 1 | Beijing, Beijing Municipality | Recruiting | Feb 6, 2025 |
| Testing HS-10365 for advanced lung cancer with RET gene fusion | Phase 2 | Shanghai, Shanghai Municipality | Recruiting | Nov 27, 2023 |
| Evaluating the safety of a new treatment for certain cancer types | Phase 1 | Chicago, Illinois and 7 other locations | Recruiting | Mar 16, 2022 |
| Supportive care model for patients with advanced lung cancer | — | Boston, Massachusetts | Recruiting | May 25, 2021 |
| Comparing treatment outcomes in lung cancer patients with different performance statuses | Phase 2 | Charlotte, North Carolina and 1 other locations | Recruiting | Feb 5, 2020 |
| TCR-T cell immunotherapy for lung cancer and solid tumors | Phase 1 | Guanzhou, Guangdong | Recruiting | Dec 19, 2018 |
All recruiting trials (8)
-
VMD-102 in liver cancer and other solid tumors
This study tests VMD-102 to see if it is safe and tolerable and to find the best dose for further study in adults with advanced liver cancer and several other solid tumors.
-
AI helps a multidisciplinary team decide NSCLC treatment
This study tests whether a local AI decision-support model can match or influence treatment choices made by a traditional MDT for non-small cell lung cancer patients.
-
Evaluating DZD6008 for advanced lung cancer with EGFR mutations
This study is testing a new oral medication called DZD6008 to see if it can safely help people with advanced lung cancer who have specific EGFR mutations.
-
Testing HS-10365 for advanced lung cancer with RET gene fusion
This study is testing a new pill called HS-10365 to see if it helps people with advanced lung cancer that has a specific gene change and who haven't had treatment before.
-
Evaluating the safety of a new treatment for certain cancer types
This study is testing a new treatment for certain types of cancer to see if it's safe for adults with recurrent or metastatic tumors.
-
Supportive care model for patients with advanced lung cancer
This study is testing a new supportive care program for people with advanced lung cancer to see if it helps them feel less stressed and more confident about managing their condition compared to standard care.
-
Comparing treatment outcomes in lung cancer patients with different performance statuses
This study is testing if immunotherapy treatments can help lung cancer patients with lower performance status feel better and live longer compared to those with better performance status.
-
TCR-T cell immunotherapy for lung cancer and solid tumors
This study is testing a new immunotherapy that uses specially modified T cells to see if it can help people with advanced lung cancer and other solid tumors.
Related topics
Quick answers
How many Nonsmall Cell Lung Cancer clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (4 trials), China (4 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 2: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.